The global Bio-pharma market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Bio-pharma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bio-pharma market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bio-pharma in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bio-pharma manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others

Segment by Application
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others